CIK 0002023658
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-21 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −9,200 | $23.00 | $212K | 145,355 |
| 2026-04-20 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −15,000 | $23.61 | $354K | 362,152 |
| 2026-04-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $23.01 | $184K | 200,641 |
| 2026-04-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $23.01 | $104K | 196,141 |
| 2026-03-25 | Raben David Chief Medical Officer | Sale 10b5-1 | −5,500 | $18.95 | $104K | 55,286 |
| 2026-03-23 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −9,200 | $18.52 | $170K | 145,355 |
| 2026-03-20 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −1,596 | $18.95 | $30K | 339,392 |
| 2026-03-19 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −6,905 | $18.78 | $130K | 339,392 |
| 2026-03-18 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −6,499 | $18.84 | $122K | 339,392 |
| 2026-03-16 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $19.66 | $157K | 205,141 |
| 2026-03-16 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $19.66 | $88K | 200,641 |
| 2026-03-09 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −36,766 | $19.17 | $705K | 339,392 |
| 2026-03-06 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −3,817 | $18.75 | $72K | 339,392 |
| 2026-03-05 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −1,786 | $18.74 | $33K | 339,392 |
| 2026-03-04 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −2,631 | $18.73 | $49K | 339,392 |
| 2026-03-04 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −2,963 | $18.25 | $54K | 145,355 |
| 2026-03-04 | Raben David Chief Medical Officer | Sale 10b5-1 | −16,300 | $18.52 | $302K | 55,286 |
| 2026-03-03 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −12,892 | $18.16 | $234K | 209,641 |
| 2026-03-03 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.16 | $82K | 205,141 |
| 2026-03-03 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −13,555 | $18.22 | $247K | 145,355 |
Page 2 of 4 · 76 trades